Start Date
April 30, 2021
Primary Completion Date
April 30, 2023
Study Completion Date
June 30, 2023
Characterization of tumor tissue by fluorescence
"* HSI Imaging of the resected specimen, from the serum and the mucous side~* FF-OCT imaging of the tumor and the healthy tissue biopsies~* Local application of Bevacizumab-IRDye800CW and visualization with the Surgvision Explorer system~* Standard anti-VEGF Immunohistochemistry and pathology"
Collaborators (1)
ARC Foundation for Cancer Research
OTHER
IHU Strasbourg
OTHER